optimizerx corp - OPRX
OPRX
Close Chg Chg %
7.87 -0.27 -3.43%
Closed Market
7.60
-0.27 (3.43%)
Volume: 99.96K
Last Updated:
Sep 8, 2026, 4:00 PM EDT
Company Overview: optimizerx corp - OPRX
OPRX Key Data
| Open $7.84 | Day Range 7.57 - 7.84 |
| 52 Week Range 4.54 - 22.25 | Market Cap $148.24M |
| Shares Outstanding 18.84M | Public Float 16.00M |
| Beta 1.09 | Rev. Per Employee N/A |
| P/E Ratio 33.46 | EPS $0.25 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 237.25K |
OPRX Performance
| 1 Week | -3.43% | ||
| 1 Month | 7.34% | ||
| 3 Months | 45.32% | ||
| 1 Year | -56.15% | ||
| 5 Years | -88.96% |
OPRX Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
6
Full Ratings ➔
About optimizerx corp - OPRX
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
OPRX At a Glance
OptimizeRx Corp.
260 Charles Street
Waltham, Massachusetts 02453
| Phone | 1-248-651-6568 | Revenue | 109.43M | |
| Industry | Packaged Software | Net Income | 5.13M | |
| Sector | Technology Services | 2025 Sales Growth | 18.781% | |
| Fiscal Year-end | 12 / 2026 | Employees | 133 | |
| View SEC Filings |
OPRX Valuation
| P/E Current | 33.461 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 45.391 |
| Price to Sales Ratio | 2.129 |
| Price to Book Ratio | 1.793 |
| Price to Cash Flow Ratio | 12.28 |
| Enterprise Value to EBITDA | 14.38 |
| Enterprise Value to Sales | 2.154 |
| Total Debt to Enterprise Value | 0.111 |
OPRX Efficiency
| Revenue/Employee | 822,774.436 |
| Income Per Employee | 38,586.466 |
| Receivables Turnover | 2.842 |
| Total Asset Turnover | 0.629 |
OPRX Liquidity
| Current Ratio | 3.043 |
| Quick Ratio | 3.043 |
| Cash Ratio | 1.099 |
OPRX Profitability
| Gross Margin | 63.299 |
| Operating Margin | 11.022 |
| Pretax Margin | 6.351 |
| Net Margin | 4.69 |
| Return on Assets | 2.949 |
| Return on Equity | 4.184 |
| Return on Total Capital | 3.324 |
| Return on Invested Capital | 3.445 |
OPRX Capital Structure
| Total Debt to Total Equity | 20.346 |
| Total Debt to Total Capital | 16.906 |
| Total Debt to Total Assets | 14.754 |
| Long-Term Debt to Equity | 16.879 |
| Long-Term Debt to Total Capital | 14.026 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Optimizerx Corp - OPRX
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 62.45M | 71.52M | 92.13M | 109.43M | |
Sales Growth
| +1.89% | +14.53% | +28.81% | +18.78% | |
Cost of Goods Sold (COGS) incl D&A
| 41.25M | 31.02M | 37.08M | 40.16M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 2.02M | 2.40M | 4.33M | 4.33M | |
Depreciation
| 85.72K | 99.85K | 111.00K | 102.00K | |
Amortization of Intangibles
| 1.94M | 2.30M | 4.22M | 4.22M | |
COGS Growth
| +24.13% | -24.79% | +19.52% | +8.31% | |
Gross Income
| 21.20M | 40.50M | 55.05M | 69.27M | |
Gross Income Growth
| -24.45% | +91.04% | +35.93% | +25.83% | |
Gross Profit Margin
| +33.95% | +56.62% | +59.75% | +63.30% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 33.49M | 53.72M | 56.99M | 57.21M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 33.49M | 53.72M | 56.99M | 57.21M | |
SGA Growth
| +20.91% | +60.41% | +6.09% | +0.37% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | 11.04M | 11.76M | 368.00K | |
EBIT after Unusual Expense
| (12.29M) | (24.26M) | (13.71M) | 11.69M | |
Non Operating Income/Expense
| 852.30K | 549.37K | 481.00K | 551.00K | |
Non-Operating Interest Income
| 852.30K | 2.19M | 329.00K | 353.00K | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | 1.45M | 6.16M | 5.29M | |
Interest Expense Growth
| - | - | +323.73% | -14.06% | - |
Gross Interest Expense
| - | 1.45M | 6.16M | 5.29M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (11.44M) | (25.16M) | (19.39M) | 6.95M | |
Pretax Income Growth
| -3,125.41% | -119.99% | +22.96% | +135.85% | |
Pretax Margin
| -18.32% | -35.18% | -21.04% | +6.35% | |
Income Tax
| - | (7.60M) | 725.00K | 1.82M | |
Income Tax - Current - Domestic
| - | 97.45K | 572.00K | 564.00K | |
Income Tax - Current - Foreign
| - | - | - | 39.00K | - |
Income Tax - Deferred - Domestic
| - | (7.70M) | 153.00K | 1.22M | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (11.44M) | (17.57M) | (20.11M) | 5.13M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (11.44M) | (17.57M) | (20.11M) | 5.13M | |
Net Income Growth
| -3,125.41% | -53.57% | -14.48% | +125.52% | |
Net Margin Growth
| -18.32% | -24.56% | -21.83% | +4.69% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (11.44M) | (17.57M) | (20.11M) | 5.13M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (11.44M) | (17.57M) | (20.11M) | 5.13M | |
EPS (Basic)
| -0.6432 | -1.0258 | -1.0993 | 0.2766 | |
EPS (Basic) Growth
| -3,023.64% | -59.48% | -7.17% | +125.16% | |
Basic Shares Outstanding
| 17.78M | 17.12M | 18.29M | 18.56M | |
EPS (Diluted)
| -0.6432 | -1.0258 | -1.0993 | 0.2701 | |
EPS (Diluted) Growth
| -3,105.61% | -59.48% | -7.17% | +124.57% | |
Diluted Shares Outstanding
| 17.78M | 17.12M | 18.29M | 19.00M | |
EBITDA
| (10.27M) | (10.82M) | 2.38M | 16.39M | |
EBITDA Growth
| -519.55% | -5.37% | +122.03% | +587.42% | |
EBITDA Margin
| -16.44% | -15.13% | +2.59% | +14.98% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 12.40 | |
| Number of Ratings | 6 | Current Quarters Estimate | 0.18 | |
| FY Report Date | 09 / 2026 | Current Year's Estimate | 0.912 | |
| Last Quarter’s Earnings | 0.16 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.05 | Next Fiscal Year Estimate | 1.10 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 5 | 5 | 5 |
| Mean Estimate | 0.18 | 0.44 | 0.91 | 1.10 |
| High Estimates | 0.22 | 0.55 | 1.00 | 1.35 |
| Low Estimate | 0.10 | 0.31 | 0.72 | 0.78 |
| Coefficient of Variance | 28.33 | 19.68 | 12.44 | 20.36 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 6 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Optimizerx Corp - OPRX
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Optimizerx Corp - OPRX
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Andrew D'Silva Chief Business Officer | 99,660 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.86 per share | 783,327.60 |
| Aug 25, 2026 | Marion K. Odence-Ford Chief Legal & Admin Officer | 90,407 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.71 per share | 697,037.97 |
| Aug 25, 2026 | Brendan Merrell CHIEF OPERATING OFFICER | 25,187 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.71 per share | 194,191.77 |
| Aug 25, 2026 | Stephen L. Silvestro Chief Executive Officer | 183,551 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.71 per share | 1,415,178.21 |
| Aug 25, 2026 | Edward Stelmakh Chief Finance & Strat Officer | 121,791 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.71 per share | 939,008.61 |
| Dec 23, 2025 | Marion K. Odence-Ford Chief Legal & Admin Officer | 93,373 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.51 per share | 1,261,469.23 |
| Dec 23, 2025 | Marion K. Odence-Ford Chief Legal & Admin Officer | 3,928 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Dec 23, 2025 | Stephen L. Silvestro Chief Executive Officer | 193,868 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $13.51 per share | 2,619,156.68 |
| Dec 23, 2025 | Stephen L. Silvestro Chief Executive Officer | 6,547 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Dec 23, 2025 | Edward Stelmakh Chief Finance & Strat Officer | 126,830 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $13.51 per share | 1,713,473.30 |
| Dec 23, 2025 | Edward Stelmakh Chief Finance & Strat Officer | 5,237 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 12, 2025 | Patrick D. Spangler Director | 44,215 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.49 per share | 773,320.35 |